February 27, 2017 by Jeffrey Woldt and Chain Drug Review
AmerisourceBergen, Andrew Mandzy, Bartell Drugs, Brian Owens, Doug Long, Jeffrey Woldt, Kantar Retail, Kristin Williams, Martin Otto, NACDS Regional Chain Conference, National Association of Chain Drug Stores, Nielsen, Peyton Howell, QuintilesIMS, regional drug chains, Steve Anderson, Thrifty White Pharmacy
2017, Issue 02-27-2017, Issues, Opinion
Although sometimes overlooked amid the swirl of activity surrounding the largest players in retail pharmacy, regional drug chains remain an integral part of the industry. The assets and aspirations of those companies — defined as operating between four and 250 stores — along with the challenges they face, were on display at the National Association
February 6, 2017 by Jeffrey Woldt and Chain Drug Review
Bartell Drugs, Brian Unmacht, George Bartell, Jeffrey Woldt
2017, Featured Articles, Issue 02-06-2017, Issues, Leading Headlines, Opinion
For Bartell Drugs and chief executive officer Brian Unmacht, 2017 is shaping up to be a watershed year. If all goes according to plan, the 127-year-old company, which for many consumers in the Puget Sound region is synonymous with community pharmacy, will begin to reap the benefits of an enterprisewide reengineering project designed to position
January 16, 2017 by Jeffrey Woldt and Chain Drug Review
ACA, Affordable Care Act, Barack Obama, Donald Trump, Jeffrey Woldt, Mike Pence, Obamacare, retail pharmacies
2017, Issue 01-16-2017, Issues, Leading Headlines, Opinion
After stumbling out of the gate early this month with an ill-conceived bid to hamstring the Office of Congressional Ethics (a plan that roused a chorus of critics, including President-elect Donald Trump, and was quickly withdrawn), Republicans in the House, along with their colleagues in the Senate, regained their footing and set about the business
January 2, 2017 by Jeffrey Woldt and Chain Drug Review
Fred's, Jeffrey Woldt, John Standley, Ken Martindale, Mike Bloom, Rite Aid, sale of the Rite Aid stores to Fred’s, Stefano Pessina, Walgreens Boots Alliance, Walgreens-Rite Aid merger
2017, Issue 01-02-2017, Issues, Opinion
The agreement struck last month for the sale of 865 Rite Aid Corp. drug stores to Fred’s Inc. is a momentous development for those companies, as well as Walgreens Boots Alliance, which after 14 months is still working to finalize the acquisition of Rite Aid. The $950 million all-cash deal will bring Fred’s stores and
December 12, 2016 by Jeffrey Woldt and Chain Drug Review
Affordable Care Act, Centers for Medicare & Medicaid Services, Health and Human Services, Jeffrey Woldt, Martin Otto, NACDS, NACDS Foundation Dinner, NACDS Week in New York, National Association of Chain Drug Stores, Seema Verma, Steve Anderson, Tom Price
2016, Issue 12-12-2016, Issues, Opinion
At the start of the month the National Association of Chain Drug Stores concluded a series of successful events in the nation’s economic and cultural capital. The much anticipated annual gathering, known as NACDS Week in New York, brings together leaders from the diverse constituents that comprise the chain pharmacy industry to take stock as
November 21, 2016 by Geoff Walden and Chain Drug Review
2016 Chain Drug Review Category Management Roundtable, Bob Candelora, Chain Drug Review, Dave Van Howe, Jeffrey Woldt, Marc Greenberger, Market Performance Group
2016, Featured Articles, Issue 11-21-2016, Issues, Leading Headlines, News, Retail News
NEW YORK — The increasing complexity of today’s consumer is making it ever more difficult to tailor stores to shoppers, retailers and suppliers said at the 2016 Chain Drug Review Category Management Roundtable in Manhattan. Conducted in tandem with Market Performance Group (MPG), the roundtable featured 20 executives representing the retailer and supplier viewpoints. Panelists
October 24, 2016 by Jeffrey Woldt and Chain Drug Review
Amazon, Bob Dylan, curbside pickup service, CVS Pharmacy, Dollar Shave Club, Google, grocery business, Jeffrey Woldt, mass market retailers, Project Como, Target, Unilever, Walmart
2016, Issue 10-24-2016, Issues, Opinion
In the early 1960s, Bob Dylan, who was just awarded the Nobel Prize in Literature, asked his listeners to “… admit that the waters/Around you have grown/And accept it that soon you be drenched to the bone/If your time to you is worth savin’/Then you better start swimmin’ or you’ll sink like a stone/For the
October 10, 2016 by Jeffrey Woldt and Chain Drug Review
Association Leadership Awards, community pharmacy, Jeffrey Woldt, NACDS, National Association of Chain Drug Stores, retail pharmacy industry, Steve Anderson
2016, Issue 10-10-2016, Issues, Opinion
Steve Anderson joined a select group of business leaders last month when he was recognized as trade association CEO of the year. As only the third winner of the honor, part of the Association Leadership Awards sponsored by CEO Update, the National Association of Chain Drug Stores president and chief executive officer earned a distinction
September 26, 2016 by Jeffrey Woldt and Chain Drug Review
2016 presidential election campaign, Affordable Care Act, Donald Trump, HealthCare.gov, Hillary Clinton, Jeffrey Woldt
2016, Issue 09-26-2016, Issues, Opinion
One of the more surprising aspects of the sad spectacle leading up to the election of a new president and new Congress in November is the lack of serious, sustained debate about health care. When the Patient Protection and Affordable Care Act was signed into law by President Obama in March 2010, the nation embarked
September 12, 2016 by Jeffrey Woldt and Chain Drug Review
Jeffrey Woldt, Martin Otto, NACDS, NACDS Total Store Expo, Steve Anderson
2016, Issue 09-12-2016, Issues, Opinion
The NACDS Total Store Expo in Boston last month has several claims to distinction. In its fourth year, the event — which brings together aspects of the industry that the association previously addressed in three separate shows — hit its stride in terms of fostering interaction between retailers and suppliers, with the Meet the Market
August 6, 2016 by Chain Drug Review
A.T. Kearney, Bob O’Meara, Chain Drug Review, Digital Disruption, health care technology, Jeffrey Woldt, Matter, pharmacy chains, retail pharmacy, Steven Collens, Todd Huseby
2016, Issue 08-08-2016, Issues, News, Retail News, Technology
CHICAGO — Retail pharmacy is no stranger to technology. For many years pharmacy operators and their supply chain partners have relied on computer-driven systems to ensure efficient distribution of products, assist pharmacists in dispensing and adjudicate insurance claims. The digital revolution is now bringing about an exponential change in technology’s impact not only on pharmacy,
August 6, 2016 by Jeffrey Woldt and Chain Drug Review
Ahold, Delhaize, Federal Trade Commission, Jeffrey Woldt, Ornella Barra, Rite Aid, Stefano Pessina, Walgreens, Walgreens Boots Alliance, Walgreens-Rite Aid merger, WBA
2016, Featured Articles, Issue 08-08-2016, Issues, Leading Headlines, Opinion
It has been slightly more than nine months since Walgreens Boots Alliance agreed to acquire Rite Aid in a $17.2 billion all-cash transaction. Since that time, speculation about whether the Walgreens-Rite Aid merger will pass muster with the Federal Trade Commission has become a staple of discussion for people involved in community pharmacy and the
July 25, 2016 by Jeffrey Woldt and Chain Drug Review
Amazon Prime Day, Amazon.com, chain pharmacies, drug stores, Greg Greeley, Jeffrey Woldt, online retailers
2016, Issue 07-25-2016, Issues, Opinion
The second annual Amazon Prime Day was held this month and, despite early technical problems that slowed down the checkout process for some customers, it was another in a series of successes for the nation’s leading online merchant. The company reported that the event was the best day in Amazon.com’s 22-year history, with sales in
June 20, 2016 by Jeffrey Woldt and Chain Drug Review
Alex Gourlay, AmerisourceBergen, Boots, Jeffrey Woldt, Ornella Barra, Rite Aid, Stefano Pessina, Walgreens, Walgreens Boots Alliance, WBA
2016, Featured Articles, Issue 06-20-2016, Issues, Leading Headlines, Opinion
The appointment of Alex Gourlay and Ornella Barra as co-chief operating officers of Walgreens Boots Alliance signals the start of a new stage in the process of forging the two companies that came together to form WBA at the close of 2014 into a new corporate culture. The two executives, whose talent, experience and leadership